BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Medicines Co (NQ: MDCO)
24.55 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(MDCO) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
Related Wikinvest articles
April 18, 2014
(Stock Blog Hub, 4/29/13)
The Medicines Company (MDCO) reported first quarter earnings of 24 cents per share, compared with the year-ago earnings of 14 cents per share. Including one-time items, the...(read more)
(Stock Blog Hub, 1/15/13)
The Medicines Company (MDCO) recently received good news with the company announcing positive results on its phase III candidate, cangrelor. Cangrelor is being...(read more)
(Morningpick, 11/1/11)
My morning pick is The Medicines Company MDCO from the Biomedical Sector. How does this company make money? The Medicines Company is focused on advancing the treatment of critical care patients...(read more)
Medicines Company (MDCO) Company Overview

There is no analysis for MDCO yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here